Aarti Drugs Limited announced that ICRA Limited has reaffirmed the credit ratings across its major debt facilities. The Long-term Fund-based Term Loan and Cash Credit (CC) facilities received an [ICRA] AA- (Stable) rating. Furthermore, the Short-term facilities, encompassing both fund-based and non-fund-based options, have been reaffirmed at [ICRA] A1+. The total facilities covered by this reaffirmation amount to ₹1,452.80 Crore, effective March 24, 2026.
Credit Rating Reaffirmation by ICRA
Aarti Drugs Limited has officially informed the stock exchanges regarding the rating actions taken by ICRA Limited on its various financing instruments. The reaffirmation process was completed following a review, confirming the existing strength of the company’s debt servicing capabilities as of March 24, 2026.
Long-Term Instrument Ratings
The core, long-term financing structures have maintained stable ratings:
- Long-term – Fund-based Term Loan: Rated at [ICRA] AA- (Stable); Reaffirmed, covering an amount of ₹253.13 Crore.
- Long-term – Fund-based CC: Rated at [ICRA] AA- (Stable); Reaffirmed, for an amount of ₹65.00 Crore.
- Long-term – Fund based Proposed Term loan: Also rated [ICRA] AA- (Stable); Reaffirmed, amounting to ₹49.67 Crore.
Short-Term and Working Capital Ratings
The working capital and immediate liquidity instruments received the highest short-term rating:
- Short-term – Fund based/ Non-fund based facilities: Reaffirmed at [ICRA] A1+, covering a significant total of ₹1,085.00 Crore.
Summary of Rated Facilities
The cumulative facilities reaffirmed by ICRA now stand at ₹1,452.80 Crore. The detailed breakdown provided in the annexure confirms the allocation across specific banking partners for both long-term loans (totaling ₹367.80 Crore) and short-term facilities (totaling ₹1,085.00 Crore). For instance, the largest component within the short-term rating is the Fund Based facilities, amounting to ₹535.00 Crore.
The company has enclosed the detailed rating rationale issued by ICRA dated March 24, 2026, for further review by stakeholders.
Source: BSE
